Fundraising Fox
/Companies
Sign in

Augmenix

1 known investors

Find your way into Augmenix

SpaceOAR Hydrogel is a polyethylene glycol-based hydrogel spacer used during prostate cancer radiation therapy to reduce urinary, sexual, and bowel side effects. It is a medical device offered to prostate cancer patients and their physicians in the United States.

BiotechHealthtechMedical Devices

Investors · 1

In the news

Augmenix Financing Will Enable Sales Growth - BioSpacebiospace.com · Jul 2016Augmenix raises $6m in Series E round - MassDevicemassdevice.com · Jul 2016Augmenix raises $11M for surgical hydrogels as Varian's purchase option expires - MassDevicemassdevice.com · Jul 2014Medical Device Developer Augmenix Raises $4.7 Million - BioSpacebiospace.com · Jul 2009

Frequently asked questions

What does Augmenix do?
SpaceOAR Hydrogel is a polyethylene glycol-based hydrogel spacer used during prostate cancer radiation therapy to reduce urinary, sexual, and bowel side effects. It is a medical device offered to prostate cancer patients and their physicians in the United States.
Who are Augmenix's investors?
Augmenix's investors include Excelestar Ventures.